Early Cancer Intervention-From Laboratory Discoveries to the Community


The NUS Centre for Cancer Research (N2CR) proudly presents Singapore's inaugural symposium for early cancer intervention research, 'Early Cancer Intervention: From Laboratory Discoveries to the Community', which will take place on 13th and 14th May 2024 at the Centre for Translational Medicine (MD6), National University of Singapore.s the demand for effective cancer prevention and early detection strategies continues to rise in Singapore, N2CR is committed to strengthening the local and regional cancer research community through facilitation and nucleation of research ideas on early cancer intervention research.
We warmly invite you to our upcoming symposium. We will showcase the growing field of early cancer intervention in Asia and will serve as a vital platform for scientists and clinicians to converge and explore the latest advancements in early cancer intervention strategies, spanning from cutting-edge research to community-centric strategies.
This symposium will focus on the following key themes :
1. Early Carcinogenesis Research 2. Advancements in Early Diagnosis and Intervention Technologies 3. Community-Centric Screening Strategies

Target Audience
Scientific researchers from academic institutions (A*Star, NUS, NUH, Duke-NUS, SGH), clinicians and industry at all levels from Singapore as well as the rest of Asia.

Guest of Honour
Prof TAN Chorh Chuan
Permanent Secretary (National Research and Development) Permanent Secretary (Public Sector Science and Technology Policy and Plans Office), Prime Minister's Office Chairman, Agency for Science, Technology and Research
Keynote Speakers
Prof Nitzan ROSENFELD, Director, Barts Cancer Institute, Queen Mary University of London Senior Group Leader, University of Cambridge, UK
Prof Joseph SUNG, Senior Vice President (Health & Life Sciences), Dean, Lee Kong Chian School of Medicine, National Technological University, Singapore
Prof YEOH Khay Guan, Senior Vice President (Health Affairs), Kishore Mahbubani Professor in Medicine and Health Policy, National University of Singapore

Call for Abstract Submission for Oral Presentation
We invite you to submit your abstracts, on the theme of Early Cancer Intervention, to be considered for inclusion in the symposium programme via this submission portal.
Please submit your abstracts as an attachment in PDF Format. Abstracts are limited to a maximum of 250 words excluding authors' affiliation.
Please refer to the Abstract Template provided.
Submission closing date: Extended to 1 April, 2024
Please click here to submit.
Only authors of shortlisted abstracts will be notified via email (by end April 2024), and invited to present at the 'Early Cancer Intervention - from Laboratory Discoveries to the Community' on 13th or 14th May 2024.
Authors selected to present their abstracts orally will be reimbursed for the cost of their symposium ticket.
For any enquiries, please email

Date and Time

Monday, 13th May 2024 8:30AM GMT+08:00


Tuesday, 14th May 2024 5:00PM GMT+08:00


Yong Loo Lin School of Medicine

Contact Email